BioAge Labs, Inc. 8-K

What Happened

• On May 8, 2026, BioAge Labs, Inc. (BIOA) announced its financial results for the quarter ended March 31, 2026 in a press release. The company filed a Current Report on Form 8-K (Item 2.02) attaching that press release as Exhibit 99.1.
• The 8-K was signed by Dov Goldstein, Chief Financial Officer. The filing also includes the cover page interactive data file (Inline XBRL).

Key Details

• Filing date: May 8, 2026 (Form 8-K reporting Item 2.02: Results of Operations and Financial Condition).
• Quarter covered: Quarter ended March 31, 2026.
• Press release attached as Exhibit 99.1 to the 8-K; detailed financial figures and commentary are contained in that press release.
• Document includes Interactive XBRL cover page (Exhibit 104).

Why It Matters

• Quarterly results and any accompanying commentary can affect investor views on revenue, cash position, guidance and near-term prospects. This 8-K confirms BioAge has publicly released its Q1 2026 results—investors should read the attached press release (Exhibit 99.1) for the company’s reported figures and management comments.
• For full context, compare the press release numbers with the company’s SEC filings (10-Q/10-K) and recent investor presentations before making investment decisions.